FindTrial
Sign In

Evaluation value of echocardiographic parameter integration system for clinical prognosis in patients with end-stage renal disease: a clinical study protocol

Evaluation value of echocardiographic parameter integration system for clinical prognosis in patients with end-stage renal disease: a clinical study protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031658
Enrollment
Unknown
Registered
2020-04-06
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage renal disease

Interventions

Gold Standard:Clinical outcome
Index test:integral system

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with end-stage renal disease admitted to our center on peritoneal dialysis and hemodialysis from April 01, 2020 to March 31, 2022.

Exclusion criteria

Exclusion criteria: 1. Patients with acute kidney injury, acute kidney injury based on chronic kidney disease; 2. Patients with structural heart disease such as rheumatic heart disease, congenital heart disease, hypertrophic cardiomyopathy, etc.; 3. Patients with renal function recovery during follow-up.

Design outcomes

Primary

MeasureTime frame
Echocardiographic parameters;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactJing Zhu

The Second Affiliated Hospital of Soochow University

zjsuzhou@163.com+86 15995739331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026